Literature DB >> 25273950

A qualitative evaluation of the psychosocial impact of family history screening in Australian primary care.

Gabrielle T Reid1, Fiona M Walter, Jon D Emery.   

Abstract

Whilst the family history is perceived as a routine part of the medical family history it is not used in a systematic way to tailor disease prevention in primary care. Family history questionnaires (FHQs) may have an important role in primary care as a screening tool to support tailored disease prevention. The potential harms and benefits of family history screening in primary care require investigation before routine adoption. This study aimed: first to explore the experience and impact of family history collection via a novel family history questionnaire and subsequent familial risk assessment, and secondly, to assess the acceptability and feasibility of using the questionnaire in Australian primary care. Twenty-eight semi-structured telephone interviews were conducted with patients already enrolled in a family history screening study through their family physician. Qualitative constant comparative analysis was undertaken of transcript data. Common themes included the way in which the family unit, individual stage of life and a number of external triggers interact and contribute to how an individual comes to terms with familial disease risk. Unique findings emerged relating to the Australian perspective of participants. Living in Australia created a barrier to effective communication amongst family members about family health, and family history collection. In addition to the vast geographical distance both within Australia, and between Australia and other countries, there was an additional sense of isolation described within an historical context. The family history screening questionnaire was considered user-friendly and a worthwhile approach to supporting disease prevention in primary care, although some participants did not retain an accurate understanding of their familial cancer risk. In conclusion, a person's response to family history screening is reliant on a complex interplay of family, personal and external factors, which in turn are driven by their stage of life. The impact of immigration and geographic isolation from family members may further complicate a person's response to undertaking family history screening.

Entities:  

Mesh:

Year:  2014        PMID: 25273950     DOI: 10.1007/s10897-014-9772-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  32 in total

Review 1.  Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.

Authors:  Sara Gandini; Francesco Sera; Maria Sofia Cattaruzza; Paolo Pasquini; Roberto Zanetti; Cinzia Masini; Peter Boyle; Carmelo Francesco Melchi
Journal:  Eur J Cancer       Date:  2005-09       Impact factor: 9.162

2.  Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter?

Authors:  K Hunt; C Emslie; G Watt
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

3.  'The family is part of the treatment really': a qualitative exploration of collective health narratives in families.

Authors:  Antje Lindenmeyer; Frances Griffiths; Jean Hodson
Journal:  Health (London)       Date:  2010-12-15

Review 4.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

Authors: 
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

5.  Family history and prostate cancer risk.

Authors:  S M Lesko; L Rosenberg; S Shapiro
Journal:  Am J Epidemiol       Date:  1996-12-01       Impact factor: 4.897

6.  Comparison of risk perceptions and beliefs across common chronic diseases.

Authors:  Catharine Wang; Suzanne M O'Neill; Nan Rothrock; Robert Gramling; Ananda Sen; Louise S Acheson; Wendy S Rubinstein; Donald E Nease; Mack T Ruffin
Journal:  Prev Med       Date:  2008-11-25       Impact factor: 4.018

Review 7.  Family history questionnaires designed for clinical use: a systematic review.

Authors:  G T Reid; F M Walter; J M Brisbane; J D Emery
Journal:  Public Health Genomics       Date:  2008-10-02       Impact factor: 2.000

8.  Primary care physicians' experience with family history: an exploratory qualitative study.

Authors:  Janet L Williams; Dave S Collingridge; Marc S Williams
Journal:  Genet Med       Date:  2011-01       Impact factor: 8.822

9.  Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care.

Authors:  Fiona M Walter; A Toby Prevost; Linda Birt; Nicola Grehan; Kathy Restarick; Helen C Morris; Stephen Sutton; Peter Rose; Sarah Downing; Jon D Emery
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

10.  Psychological impact of family history risk assessment in primary care: a mixed methods study.

Authors:  Linda Birt; Jon D Emery; A Toby Prevost; Stephen Sutton; Fiona M Walter
Journal:  Fam Pract       Date:  2014-04-12       Impact factor: 2.267

View more
  2 in total

1.  Genetics in primary care: validating a tool to pre-symptomatically assess common disease risk using an Australian questionnaire on family history.

Authors:  Elisa J F Houwink; Olga R Hortensius; Kees van Boven; Annet Sollie; Mattijs E Numans
Journal:  Clin Transl Med       Date:  2019-05-02

2.  The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Authors:  Jennifer G Walker; Finlay Macrae; Ingrid Winship; Jasmeen Oberoi; Sibel Saya; Shakira Milton; Adrian Bickerstaffe; James G Dowty; Richard De Abreu Lourenço; Malcolm Clark; Louise Galloway; George Fishman; Fiona M Walter; Louisa Flander; Patty Chondros; Driss Ait Ouakrim; Marie Pirotta; Lyndal Trevena; Mark A Jenkins; Jon D Emery
Journal:  Trials       Date:  2018-07-25       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.